Growing community of inventors

Villeurbanne, France

Fabien Zoulim

Average Co-Inventor Count = 4.44

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Fabien ZoulimLykke Pedersen (1 patent)Fabien ZoulimSouphalone Luangsay (1 patent)Fabien ZoulimSoren Ottosen (1 patent)Fabien ZoulimDavid Durantel (2 patents)Fabien ZoulimBarbara Testoni (2 patents)Fabien ZoulimMaelle Locatelli (1 patent)Fabien ZoulimChristian Trepo (1 patent)Fabien ZoulimJean Pierre Quivy (1 patent)Fabien ZoulimSandra Durantel (0 patent)Fabien ZoulimFabien Zoulim (2 patents)Lykke PedersenLykke Pedersen (20 patents)Souphalone LuangsaySouphalone Luangsay (5 patents)Soren OttosenSoren Ottosen (4 patents)David DurantelDavid Durantel (2 patents)Barbara TestoniBarbara Testoni (2 patents)Maelle LocatelliMaelle Locatelli (1 patent)Christian TrepoChristian Trepo (1 patent)Jean Pierre QuivyJean Pierre Quivy (1 patent)Sandra DurantelSandra Durantel (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (1 from 832,880 patents)

2. Centre National De La Recherche Scientifique (1 from 5,089 patents)

3. Institut National De La Sante Et De La Recherche Medicale (1 from 1,744 patents)

4. Universite Claude Bernard – Lyon1 (1 from 214 patents)

5. Hospices Civils De Lyon (1 from 43 patents)

6. Centre Leon Berard (1 from 34 patents)


2 patents:

1. 11732262 - Use of FUBP1 inhibitors for treating hepatitis B virus infection

2. 11555191 - Inhibitor for use for preventing and/or treating an infection with hepatitis B virus

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…